Jerry Ryan HOLDER
9Patents
3h-index
34Co-inventors
53Inventor score
Filing activity: May 7, 2002 → Jan 28, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8168592B2 | CGRP peptide antagonists and conjugates | Chemistry; Metallurgy | 16 | Active |
| US7368433B2 | Peptides and methods for the control of obesity | Human Necessities | 10 | Expired |
| US10905772B2 | Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR) | Chemistry; Metallurgy | 3 | Active |
| US7034004B2 | Peptides and methods for the control of obesity | Human Necessities | 3 | Expired |
| US10941182B2 | Apelin polypeptides | Chemistry; Metallurgy | 0 | Active |
| US12214051B2 | Method of treating or ameliorating metabolic disorders using GLP-1 receptor agonists conjugated to antagonists for gastric inhibitory peptide receptor (GIPR) | Chemistry; Metallurgy | 0 | Active |
| US11807693B2 | Apelin polypeptides | Chemistry; Metallurgy | 0 | Active |
| US9636418B2 | Potent and selective inhibitors of NAV1.7 | Human Necessities | 0 | Active |
| US10344060B2 | Potent and selective inhibitors of Nav1.7 | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.